News & Views
€800K Grant supports Large B-cell Lymphoma Project
Jul 15 2022
Therapeutics developer Lead Pharmaceutical (Oss, Netherlands) and French medicinal chemistry and custom synthesis company Oxeltis, have been awarded an €800K ($842K) grant from EUREKA Eurostars for a three year project aimed at developing a first-in-class small molecule therapy for diffuse large B-cell lymphoma (DLBCL). This aggressive, fast-growing blood cancer that develops from B-cells in the lymphatic system, affects approximately 115,000 people per year worldwide, of which 50,000 were said to be in Europe and the US
The current first-line treatment for DLBCL, a regimen combining an antibody therapy with four chemotherapy drugs known as R-CHOP, does not cure 30-50% of DLBCL patients, who eventually relapse.
Arthur Oubrie, CSO of Lead Pharma said: “We are delighted that our approach to combat DLBCL has been awarded a Eurostars grant. We look forward to joining forces with Oxeltis, who will bring extra power in organic and medicinal chemistry to the joint project team.”
Stephane Salamone、化学Montpelli主管er-based Oxeltis, said: “We are pleased to contribute to Lead Pharma’s innovation in drug discovery, the EPIGENEXT project perfectly matches Oxeltis’ capacity to be a medicinal chemistry partner and is aligned with the company’s strategy to invest in long-term partnerships.
Eurostars is a European program that supports innovative SMEs and project partners (small and medium-sized companies, universities, research organisations and other types of organisations) by funding international collaborative R&D and innovation projects. The Program is run by EUREKA, an intergovernmental network which involves 37 countries.
更多的信息online
Digital Edition
International Labmate 47.5 - July 2022
July 2022
In This Edition Chromatography Articles - The Importance of Understanding Pump Flow - Automated Sample Preparation: The Missing Hyphen to Hypernation Mass Spectrometry & Spectroscopy Arti...
View all digital editions
Events
AACC Annual Meeting & Clinical Lab Expo
Jul 24 2022Chicago, IL, USA
Jul 24 2022Virtual event
ACS National Meeting & Expo, Fall 2022
Aug 21 2022Chicago, IL, USA & Online
Aug 22 2022Frankfurt, Germany
Aug 27 2022Maastricht, Netherlands